Goldman Sachs Maintains Buy on ArcBest, Raises Price Target to $165

Benzinga Newsdesk www.benzinga.com Positive 74.0%

Neg 0% Neu 0% Pos 74%

Goldman Sachs analyst Jordan Alliger maintains ArcBest (NASDAQ:ARCB) with a Buy and raises the price target from $117 to $165.